Fraunhofer-Institut für Zelltherapie und Immunologie (IZI)
About Fraunhofer-Institut IZI
The Fraunhofer Institute for Cell Therapy and Immunology (IZI) is a member of the Fraunhofer Group for Life Sciences and was founded in BIO CITY Leipzig on April 29, 2005 on the occasion of the European Immunology Day. The aim of the institute is to find special solutions to problems at the interface of medicine, biosciences and engineering for partners from the medical industry and business. Its core competencies lie in regenerative medicine, i.e. in cell therapy approaches for the restoration of dysfunctional tissues and organs through to biological replacement with tissue cultivated in vitro (tissue engineering). Cellular and immunological defense and control mechanisms must be identified and integrated into process and product development so that the tissue can grow without problems.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Employees: 10,001+
- Industry : Pharma
